I originated the thread and what I meant by 40c range was an sp...

I originated the thread and what I meant by 40c range was an sp somewhere between 40c and 49c. Sorry if not clear. I started this thread when the price had just dropped into the 50c range.

Happy for disagreement, but I still believe in my prediction, although it was made before the recent data related to Axiron prescriptions, which perhaps indicates the 40c range might be a little further away.

My reasoning is laid out in a long post if you want to read back. I am not going to type it again.

The ultra brief version is:-
1. Nothing good coming out of that pipeline for many years.
2. Management running show for themselves - unaccountable to holders.
3. Axiron sales effectively capped by royalty deal.
4. No new sources of decent revenue.
5. Patents expire
6. No new markets opened up for existing products - management can't be bothered.
7. Axiron revenues will eventually start falling - drugs don't last forever.

equals trading in the 40c range eventually.

Just cause it went up by 4c since I posted doesn't change a thing in my mind.

Hey, through no action of management or Lilly, Axiron sales may continue to grow via word of mouth - who knows.

So good luck to you if you think differently, I still haven't sold all of my shares yet, so glad to be wrong. If it clicks another cent I will sell another lot.